Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Merideth M. Wendland"'
Autor:
Deborah T. Blumenthal, Robin Buerki, Mitchell Machtay, Valerie Panet-Raymond, Stephanie L. Pugh, Nirav Patil, Eashwar Somasundaram, James R. Connor, Andrew E. Sloan, H. Ian Robins, Grant K. Hunter, Marta Penas-Prado, Justin D. Lathia, Serah Choi, Kristin A Waite, John C. Flickinger, Lynn S. Ashby, Maria Werner-Wasik, Joshua B. Rubin, Michael E. Berens, Merideth M Wendland, Mark R. Gilbert, Jill S. Barnholtz-Sloan, Minesh P. Mehta
Publikováno v:
Journal of Neuro-Oncology
Background/purpose Glioblastoma (GBM) is the most common primary malignant brain tumor. Sex has been shown to be an important prognostic factor for GBM. The purpose of this study was to develop and independently validate sex-specific nomograms for es
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad1214f53bf74a285d0e66449367b249
http://europepmc.org/articles/PMC8651582
http://europepmc.org/articles/PMC8651582
Autor:
Michael E, Scheurer, Renke, Zhou, Mark R, Gilbert, Melissa L, Bondy, Erik P, Sulman, Ying, Yuan, Yanhong, Liu, Elizabeth, Vera, Merideth M, Wendland, Emad F, Youssef, Volker W, Stieber, Ritsuko R, Komaki, John C, Flickinger, Lawrence C, Kenyon, H Ian, Robins, Grant K, Hunter, Ian R, Crocker, Samuel T, Chao, Stephanie L, Pugh, Terri S, Armstrong
Publikováno v:
Neuro-oncology advances. 4(1)
We sought to identify clinical and genetic predictors of temozolomide-related myelotoxicity among patients receiving therapy for glioblastoma.Patients (23% of patients developed myelotoxicity (Myelotoxicity during concurrent chemoradiation with temoz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::91303e8dafb71bee2f0fc6e0d906fef9
https://pubmed.ncbi.nlm.nih.gov/36299794
https://pubmed.ncbi.nlm.nih.gov/36299794
Autor:
H. Ian Robins, Kenneth Aldape, David A. Reardon, Merideth M Wendland, Elizabeth R. Gerstner, Jeffrey Raizer, James Battiste, Minesh P. Mehta, Peixin Zhang, John DeGroot, Lyndon Kim, Edward Pan, Eudocia Q. Lee, Patrick Y. Wen, Ryan Merrell, John L. Villano, Jennifer Connelly, Naveed Wagle, Steven J. Chmura
Publikováno v:
Cancer. 126:2821-2828
Background Targeting vascular endothelial growth factor (VEGF) alone does not improve overall survival (OS) in recurrent glioblastoma (rGBM). The angiopoiein (Ang)-TIE2 system may play a role in tumor survival under VEGF inhibition. We conducted a ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93d67824adbb342bf7a9b10fa9500ce7
https://doi.org/10.1002/cncr.32811
https://doi.org/10.1002/cncr.32811
Autor:
Michael E Scheurer, Renke Zhou, Mark R Gilbert, Melissa L Bondy, Erik P Sulman, Ying Yuan, Yanhong Liu, Elizabeth Vera, Merideth M Wendland, Emad F Youssef, Volker W Stieber, Ritsuko R Komaki, John C Flickinger, Lawrence C Kenyon, H Ian Robins, Grant K Hunter, Ian R Crocker, Samuel T Chao, Stephanie L Pugh, Terri S Armstrong
Publikováno v:
Neuro-Oncology Advances. 4
Background We sought to identify clinical and genetic predictors of temozolomide-related myelotoxicity among patients receiving therapy for glioblastoma. Methods Patients (n = 591) receiving therapy on NRG Oncology/RTOG 0825 were included in the anal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa6d6daf997ef278903e007affaf4560
https://doi.org/10.1093/noajnl/vdac152
https://doi.org/10.1093/noajnl/vdac152
Autor:
Merideth M Wendland, Jeffrey S. Wefel, David Roberge, Paul D. Brown, Christina A. Meyers, Nadia N. Laack, Ali Choucair, Deepak Khuntia, Stephanie L. Pugh, Deborah Watkins Bruner, Sherry Fox, John H. Suh
Publikováno v:
Neurooncol Pract
Background This study evaluated the association between health-related quality of life (HRQOL) and cognition in patients receiving memantine for prevention of cognitive dysfunction during whole-brain radiotherapy (WBRT). Methods Adult patients with b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c8c5cc781bffd892462e9682a66e6cb
https://doi.org/10.1093/nop/npy038
https://doi.org/10.1093/nop/npy038
Autor:
Grant K. Hunter, Mark R. Gilbert, H. Ian Robins, David Brachman, Ian R. Crocker, Jeffrey S. Wefel, Stephanie L. Pugh, Terri S. Armstrong, Merideth M Wendland, Kevin S. Roof, Minhee Won, Paul D. Brown, Minesh P. Mehta
Publikováno v:
Neuro Oncol
Background Results of NRG Oncology RTOG 0825 reported adding bevacizumab to standard chemoradiation did not significantly improve survival endpoints and resulted in greater decline in neurocognitive function (NCF) and patient-reported outcomes (PRO)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9919ba2d2e50c394c7a9df213e46a97d
https://europepmc.org/articles/PMC8661434/
https://europepmc.org/articles/PMC8661434/
Autor:
H. Ian Robins, Minesh P. Mehta, David Brachman, Jeffrey S. Wefel, Samuel T. Chao, Stephanie L. Pugh, Terri Armstrong, Paul D. Brown, Mark R. Gilbert, Merideth M Wendland, William A. Hall, Maria Werner-Wasik, Kevin S. Roof, Walter J. Curran, Benjamin Movsas
Publikováno v:
Neurosurgery. 84:66-76
Background The influence of subtotal resection (STR) on neurocognitive function (NCF), quality of life, and symptom burden in glioblastoma is unknown. If bevacizumab preferentially benefits patients with STR is unknown. Objective To examine these unc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::caab7892b1306cebe221e65e2c2e4a7b
https://doi.org/10.1093/neuros/nyy003
https://doi.org/10.1093/neuros/nyy003
Autor:
Frank S. Lieberman, Deborah T. Blumenthal, Luis Souhami, Minesh P. Mehta, Dennis C. Shrieve, Benjamin W. Corn, Kirsten Hopkins, Egils Valeinis, Felix Bokstein, David G Brachman, Peixin Zhang, Maria Werner-Wasik, Minhee Won, Grant K. Hunter, Merideth M Wendland, Mark R. Gilbert, Steven P. Howard, Cliff G. Robinson, Paul D. Brown
Publikováno v:
Neuro-Oncology. 20:966-974
Background We previously reported the unexpected finding of significantly improved survival for newly diagnosed glioblastoma in patients when radiation therapy (RT) was initiated later (>4 wk post-op) compared with earlier (≤2 wk post-op). In that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbc56e16929b19b8a782361b9bfcee19
https://doi.org/10.1093/neuonc/noy017
https://doi.org/10.1093/neuonc/noy017
Autor:
Andrew A. Kanner, Vijayananda Kundapur, Stephanie L. Pugh, Vinai Gondi, Chip Caine, Wolfgang A. Tomé, Wenyin Shi, Albert S. DeNittis, Minesh P. Mehta, Jeffrey Greenspoon, Andre Konski, Ben W Corn, Howard A. Rowley, Glenn Bauman, Merideth M Wendland, Sunjay Shah, Lisa A. Kachnic
Publikováno v:
Journal of Clinical Oncology. 32:3810-3816
Purpose Hippocampal neural stem-cell injury during whole-brain radiotherapy (WBRT) may play a role in memory decline. Intensity-modulated radiotherapy can be used to avoid conformally the hippocampal neural stem-cell compartment during WBRT (HA-WBRT)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ece26c2d7b9eb6bc4fd2c90d18eaae1e
https://doi.org/10.1200/jco.2014.57.2909
https://doi.org/10.1200/jco.2014.57.2909
Autor:
Manmeet Ahluwalia, Helen A. Shih, Amyn M. Rojiani, Shawn Malone, Minesh P. Mehta, Lynn S. Ashby, John B. Fiveash, Maria Werner-Wasik, Minhee Won, Hsiang Hsuan Michael Yu, Philip J. Stella, Volker W. Stieber, Merideth M Wendland, Patrick Y. Wen, Nimish Mohile, Prakash Chinnaiyan, Andrew Y. Kee
Publikováno v:
Neuro-oncology. 20(5)
Background This phase II study was designed to determine the efficacy of the mammalian target of rapamycin (mTOR) inhibitor everolimus administered daily with conventional radiation therapy and chemotherapy in patients with newly diagnosed glioblasto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1777790942fee483a533576485def801
https://pubmed.ncbi.nlm.nih.gov/29608764
https://pubmed.ncbi.nlm.nih.gov/29608764